Janssen Sciences Ireland is a state-of-the-art biopharmaceutical manufacturing facility based in Ringaskiddy, Co. Cork. Innovative cancer therapies and medicines for immune-related diseases are manufactured at the facility. Established in 2005 the site initially manufactured 2 commercial products, today 5 commercial products (Simponi, Stelara, Sylvant, Darzalex and Tremfya) are manufactured on site. Janssen Sciences currently employs approx. 500 people.
However, with a new €300m Fed Batch plant expansion project currently under construction in Ringaskiddy (BioCork2) staff numbers on site are set to reach 700/750.